Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity APLS - Apellis Pharmaceuticals, Inc.
789 M
LAST VALUE
-5.42%
2 YEAR CAGR
31.12%
5 YEAR CAGR
65.23%
10 YEAR CAGR